Based on the relationship between circHMGCS1–016 and CD8+ T cells, we suspect that the circHMGCS1–016 reprogram tumor immune microenvironment through synchronously regulating CD73 and GAL-8 expression. This evidence concerns the gene NT5E and neoplasm.